SHAWNETTE GAINES: Open Payments
NPI 1649527813 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 52 payments from 18 companies in 2025. Trend: 2023 $1,729 · 2024 $1,744 · 2025 $1,287
Food & beverage: $1,287
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $223 |
| Novartis Pharmaceuticals Corporation | 10 | $177 |
| Medtronic, Inc. | 1 | $134 |
| Alnylam Pharmaceuticals Inc. | 4 | $130 |
| Merck Sharp & Dohme LLC | 5 | $88 |
| Novo Nordisk Inc | 3 | $69 |
| PFIZER INC. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Boston Scientific Corporation | 2 | $56 |
| Biosense Webster, Inc. | 1 | $48 |
Products named: CAMZYOS, LEQVIO, MICRA, ONPATTRO, VERQUVO, Wegovy, VYNDAQEL, WAINUA.
Industry payments across LA — which companies pay providers there.
